An international regulatory commission convened by scientific academies is a premature and problematic approach to governing human germline genome editing. To be legitimate, ideas of the right form of governance in this emerging and highly consequential area of research need to be opened up to a wider diversity of views and voices.
Researchers demonstrated that several findings in Alzheimer’s disease are observed across disorders, identifying potential targets for therapeutic development.
This article discusses the journeys of three gene therapy startups in South Korea, Japan, and China, and the products they are developing.
Biomolecules in living cells can be imaged using an infrared transmission microscopy technique that screens out the effects of water.
Symbiosis’ investment in automated technology will enhance the manufacture of a range of drug modalities and product-specific processes.
Research in zebrafish and mouse models reveals targeting EGLN2 could potentially reduce inflammation and slow down the progression of ALS.
Findings suggest approaches to limit fibrotic scarring could improve outcomes for GBM patients receiving surgical, radiation or macrophage-targeting therapies.
Technologies for generating superphages and optimizing phage cocktails are poised to overcome antibiotic resistance and resolve microbiome dysbiosis.
The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established biopharma companies require innovative solutions…
New research in fruit flies reveals key changes to both chromosome structure and gene expression that affect stem cell function during aging.
In continuous AAV manufacturing in insect cells, as continuous manufacturing goes on, many defective viruses eventually stop the process.
